Abingdon Health Plc (AIM:ABDX)
6.75
0.00 (0.00%)
At close: Dec 5, 2025
Abingdon Health Revenue
In the fiscal year ending June 30, 2025, Abingdon Health had annual revenue of 8.43M GBP with 37.39% growth. Abingdon Health had revenue of 5.34M in the half year ending June 30, 2025, with 81.83% growth.
Revenue
8.43M
Revenue Growth
+37.39%
P/S Ratio
3.47
Revenue / Employee
67.98K
Employees
124
Market Cap
29.25M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Abingdon Health News
- 9 months ago - UK Stock Market News: Abingdon Health, Wood Group, Team Internet - The Armchair Trader
- 11 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 1 year ago - Small Cap Stocks: Hummingbird, LPA Group, Cadence Minerals - The Armchair Trader